BVS Jun 2024 2.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:03AM EDT. Market open.
| Previous close | 2.7000 |
| Open | 2.7000 |
| Bid | 3.6000 |
| Ask | 5.5000 |
| Strike | 2.50 |
| Expiry date | 2024-06-21 |
| Day's range | 2.7000 - 2.7000 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
ZacksBiogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody
Biogen's (BIIB) Qalsody is the first therapy approved to treat a rare genetic form of ALS in Europe
ZacksMerck (MRK) to Buy Private Ophthalmology Company EyeBio
Merck's (MRK) acquisition of EyeBio is set to add the latter's lead pipeline candidate, Restoret, a novel Wnt agonist antibody being developed for treating retinal diseases.
ZacksJ&J (JNJ) to Buy Rights to Novel Atopic Dermatitis Candidate
J&J (JNJ) is set to acquire Yellow Jersey Therapeutics, which holds NM26 rights, from Numab's shareholder, for a purchase price of $1.25 billion in cash.
© 2024 Yahoo. All rights reserved.